Introduction {#sec1-1}
============

*Ahara* (food) is one of the tripods of life as per Ayurveda classics.\[[@ref1]\] The transforming unit from "food" into nutrition is called as "*Agni*" (digestive factors), which forms the basis upon which the Ayurveda system is built.\[[@ref2]\] According to Charaka, *Mamsakshaya* (wasting) persons are considered under *Ashtau-ninditiya Purusha* (eight despicable persons)\[[@ref3]\] *Dalhana* has described *Karshya as* the person having lean and thin body personality, who is a patient of *Mamsakshaya*.\[[@ref4]\]

According to Ayurveda classics, *Rukshannapana Sevana* (indulgence of dry food items), *Langhana* (fasting), *Pramitashana* (less than normal quantity of diet) or diet that aggravates *Vata* (dry, astringent), *Atishrama* (excessive exercise), *Atisnana* (excess bath), *Ruksha Udvartana* (dry powder massage), *Kriyatiyoga* (excessive work), *Chinta* (worries), *Bhaya* (fear), *Shrama* (excessive physical and mental activity), *Shoka* (grief), *Vega-Nidra-Trusha-Kshudha-Nigraha* (suppression of natural urges, such as sleep, thirst, and hunger), *Ati Maithuna* (excessive sexual intercourse), *Prakriti* (constitution), *Beeja Dosha* (heredity), *Jara* (old age), *Vikara anushaya* (continued illness), and *Krodha* (anger) make person lean.\[[@ref5]\] The *Mamsakshaya* person does not tolerate physical exercise, hunger, thirst, disease, and drugs.\[[@ref6]\] The lean person has *Shushka-Sphika*, *Shushka-Udara*, *Shushka-Greeva* (emaciation of buttocks, abdomen, and neck), *Vyayamam Atisauhityam* (intolerance of physical exercise), *Dhamanijal Santataha* (prominent vascular network) *Twagasthi shosha* (remnant of skin and bone), *Kshutpipasamay* (suffering from hunger and thirst), *Sthoolaparva* (thick nodes), *Atishitoshna-Maithunasahatva* (cannot tolerate much cold, heat, and sexual intercourse).\[[@ref7]\]

*Mamsakshaya* is *Vata* dominant disease. Treatments such as *Bhrimhana* and *Rasayana* have been advocated in the classics for its management. The selected drug *Kharjura* is described in *Bhavaprakasha*.\[[@ref8]\] It has the property of *Vatanulomana*\[[@ref9]\] and *Bhrimhana*.\[[@ref10]\] The present study is aimed to evaluate the effect of *Kharjurapaka* (KP) on *Mamsakshaya* (lean) patients.

Materials and Methods {#sec1-2}
=====================

Patients having the clinical features of "*Mamsakshaya*" such as *Shushka-Sphika*, *Shushka-Udara*, *Shushka-Greeva* (emaciation of buttocks, abdomen, and neck), *Dhamani Jala Santataha* (visible web of veins) *Twagasthi shosha* (remnant of skin and bone), *Sthoolaparva* (thick nodes), *Glani* (giddiness), and *Alpa Nidra* (inadequate sleep) attending the out patient department and inpatient department of the hospital were selected irrespective of caste, religion, occupation, and sex. The present clinical trial has been carried out after obtaining approval from Institutional Ethics Committee (No.: PGT/7-A/Ethics/2013-14/1767, Dated: September 10, 2013). The trial was registered in Clinical Trial Registry-India (CTRI/2015/07/006021, Dated: July 16, 2015). Written informed consent has been taken from all the patients before starting the trial. The study was designed as open-label, randomized placebo controlled clinical trial.

Inclusion criteria {#sec2-1}
------------------

Patients between 16 and 50 year age group without any bar of race, religion, and sexPatients having low body weight (15--20% below than normal for their age and height) and lower body mass index (BMI) (under 18.5) with clinical features of *Mamsa Dhatu Kshaya*Patients having proper *Agnibala* (digestive power) were selected.

Exclusion criteria {#sec2-2}
------------------

Patients having any systemic disease or history of chronic diseases such as tuberculosis, cancer, and autoimmune diseases which cause weight loss.

Grouping and posology {#sec2-3}
---------------------

A total of 34 patients were registered for the present study, and coin toss method was adopted for randomization of patients. Patients were divided into two groups:

Group A (treatment group): KP 20 g once in a day with normal water was administered for 30 daysGroup B (control group): Placebo tablet (500 mg) of roasted wheat flour was administered once in a day with normal water for 30 days.

Preparation method of *Kharjurapaka* {#sec2-4}
------------------------------------

KP was prepared in the Department of *Rasa Shastra* and *Bhaishajya Kalpana* by following classical method of *Paka* preparation.\[[@ref11]\] *Kharjura* (*Phoenix dactylifera* Linn.) was collected and its seeds were taken out. *Kharjura* pulp was made in to small pieces. Then, *Kharjura* and cow ghee were taken in the ratio of 10:1 and it was fried on mild temperature for 10--12 min and was stirred continuously so that it would not get scorched. As the fibril consistency was observed, then frying process was stopped and the process of preparation of *Paka* (in the form of *Modaka*) was done. *Kharjura* was procured from local market.

Investigations {#sec2-5}
--------------

Routine pathological tests such as (hemoglobin %, erythrocyte sedimentation rate, random blood sugar), urine (routine microscopic and macroscopic), stool (routine microscopic and macroscopic), and biochemical investigation (serum cholesterol, serum triglyceride, fasting blood sugar, high-density lipoprotein cholesterol, serum low-density lipoprotein, total protein, serum albumin to globulins ratio) were carried out to rule out any pathology before treatment.

Criteria for assessment of therapy {#sec2-6}
----------------------------------

### Subjective parameter {#sec3-1}

It has been mainly assessed on improvement in cardinal signs and symptoms of disease with the help of scoring pattern such as follows:

*Aayasa* (lassitude)0: No *Aayasa*1: Little *Aayasa* in doing hard work2: Moderate *Aayasa* in doing hard work3: Excessive *Aayasa* in doing routine work.*Glani* (giddiness)0: No *Glani* at the level of physique, senses, and psyche1: Feel *Glani* at any level of physique but not appear on the face2: Little *Glani* at any level of physique, senses, and psyche3: Excessive *Glani* at any level of physique, senses, and psyche.*Dhamani Jala Darshana* (prominent vasculature)0: Not visible easily even after pressure1: Visible and prominent on pressure2: Visible3: Prominent.*Sthula Parva* (knee, elbow, ankle, wrist joint)0: Deeply seated with extra fat1: Covered2: Prominent3: Relatively look larger.*Kapola Gata Vasa* (pad of fat on cheek)0: Cheeks everted1: On surface level2: Cheeks inside3: Cheeks inside with zygomatic bones prominent.*Daurbalya* (fatigue)0: Not feeling *Daurbalya* in doing any hard work1: Not feeling *Daurbalya* in doing easy work2: Feeling *Daurbalya* in doing little work3: Feel *Daurbalya* in rest position.*Shoka* (grief)0: No sorrow even for reasonable cause1: Sorrowful only for reasonable cause2: Sorrowful even nonreasonable cause without anybody gesture3: Most sorrowful for no cause, unable to control his feelings, body gestures.*Nidra* (sleep)0: 6--8 h deep sleep1: 6--8 h sleep but disturbed once2: \<6 h sleep but disturbed twice3: \<6 h sleep but disturbed frequently.

### Objective parameter {#sec3-2}

Anthropometrical parameters such as BMI, weight, chest circumference, mid-arm circumference, and also skin fold thickness -- biceps, triceps, and abdomen.

Statistical analysis {#sec2-7}
--------------------

The statistical tests such as paired and unpaired *t*-test were applied for significance. Computer software SigmaStat (Systat Software, San Jose, California) was used for the calculation of statistical data.

Observation {#sec1-3}
===========

A total of 34 patients (17 in Group A and 17 in Group B) were registered in the trial, and out of which, 30 completed (15 in each group) the treatment. Age-wise distribution shows that 52.9% of the patients were between 16 and 25 years, 32.4% were in the age of 26--35 years, 14.7% were 36--50 years of age group. Majority of the patients, i.e., 67.6% were female while 32.4% were male. Maximum, i.e., 71% patients were taking vegetarian diet whereas 29% patients were taking mixed type of diet. The present study shows that maximum 76% patients were taking *Katu Rasa Pradhana* (pungent-dominant taste) diet whereas 74% patients had dominance of *Lavana Rasa* in their diet. Maximum 59% patients were taking *Ruksha Guṇa Pradhana* (dry-dominant property) diet whereas 47% patients were taking *Ushna Guṇa Pradhana* (hot-dominant property) diet and 44% patients were taking *Sheeta Guna Pradhana* (cold dominant property) diet. 41.18% patients had a habit of *Divaswapa* (daytime sleep) while 47.06% patients had a history of *Ratrijagarana* (late night sleep). Maximum, 58.83% patients, had the habit of *Kshudha Vega Vidharana* (suppression of hunger) whereas in 38.24% of the patients had a history of *Trishna Vega Vidharana* (suppression of thirst).

Results {#sec1-4}
=======

Effect of therapy on chief complaints {#sec2-8}
-------------------------------------

Group A depicted highly significant (*P* \< 0.001) results in *Aayasa*, *Glani*, *Daurbalya*, *Shoka*, and *Nidra* and significant (*P* \< 0.05) results in *Dhamani Jala Darshana*, *Kapolgatavasa*, and *Sthula Parva* \[[Table 1](#T1){ref-type="table"}\]. In Group B, highly significant (*P* \< 0.001) effects on *Aayasa*, *Daurbalya*, *Shoka*, and *Nidra* and insignificant results depicted in *Glani*, *Dhamani Jala Darshana*, *Kapolgatavasa*, and *Sthula Parva* \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of *Kharjurapaka* on *Lakshanas* of *Mamsakshaya* in Group A

![](AYU-36-404-g001)

###### 

Effect of placebo tab on *Lakshanas* of *Mamsakshaya* in Group B

![](AYU-36-404-g002)

Effect of therapy on anthropometrical parameter and skin fold thickness {#sec2-9}
-----------------------------------------------------------------------

KP in Group A rendered highly significant (*P* \< 0.001) results in reducing value of BMI, fat%, and weight, and placebo tablet in Group B rendered highly significant (*P* \< 0.001) decrease in weight and insignificant change in BMI and fat% \[Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\].

###### 

Effect of *Kharjurapaka* on weight, fat%, and body mass index in Group A (*n*=15)

![](AYU-36-404-g003)

###### 

Effects of placebo tablet on weight, fat%, body mass index in Group B (*n*=15)

![](AYU-36-404-g004)

Group A depicted significant (\<0.01) results in reducing value in millimeter in chest circumference, forearm circumference, mid-arm circumference, mid-thigh circumference and insignificant result in mid-calf circumference \[[Table 5](#T5){ref-type="table"}\]. Group B rendered significant (\<0.01) results in reducing value in millimeter in chest circumference, forearm circumference, mid-arm circumference, mid-thigh circumference, and mid-calf circumference \[[Table 6](#T6){ref-type="table"}\]. Group A depicted significant results in reducing value in millimeter in all the skin fold thickness (biceps, triceps, abdomen) and highly significant (\<0.001) result in skin fold thickness of triceps and abdomen and significant result in reducing value in millimeter in skin fold thickness of biceps in Group B \[Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}\].

###### 

Effect of *Kharjurapaka* on anthropometrical parameter and skin fold thickness in Group A (*n*=15)

![](AYU-36-404-g005)

###### 

Effects of placebo tablet on anthropometrical parameters and skin fold thickness in Group B (*n*=15)

![](AYU-36-404-g006)

Comparative efficacy of therapy {#sec2-10}
-------------------------------

In *Glani* and fat%, Group A had provided better results than Group B \[[Table 7](#T7){ref-type="table"}\]. The observations on contingency table were not significantly related as *P* value in comparative groups Group A and Group B (*P* \> 0.05). This suggested that change occurred with the treatments was not enough to exclude the possibility that the difference was due to chance. Hence, both the groups have parallel effect on symptom of *Mamsakshaya* score of disease according to statistical analysis \[Tables [8](#T8){ref-type="table"} and [9](#T9){ref-type="table"}\].

###### 

Comparative efficacy of treated Group A with control Group B on *Lakshanas* of *Mamsakshaya*

![](AYU-36-404-g007)

###### 

Comparative efficacy of treated Group A with control Group B on weight, fat%, and body mass index

![](AYU-36-404-g008)

###### 

Comparative efficacy of treated Group A with Control Group B on anthropometrical parameter and skin fold thickness

![](AYU-36-404-g009)

Discussion {#sec1-5}
==========

*Mamsa Dhatu Kshaya* causes the increase of *Vayu* and *Aakash Mahabhuta*; consequently, this causes increase of *Vata Dosha* which is composed of these *Mahabhutas*.\[[@ref12]\] Charaka has quoted that naming all types of diseases in definite terms is not possible, when aggravated the same *Dosha* may cause manifold diseases depending upon the various etiological factors and the sites of manifestation.\[[@ref13]\] Hence, *Mamsakshaya* is taken as symptom and treated with KP. Similarly, in *Mamsakshaya*, there is a predominance of *Vata Dosha* which can be alleviated by the treatment of *Brimhaniya Dravyas* composed of *Prithvi* and *Jala Mahabhuta*. *Ahara Dosha* is the main predisposing factor for this disease and *Alpashana* and *Vishamashana* (improper diet) specially results in the advancement of *Mamsakshaya*. Pharmacotherapies such as *Bhrimhana*, *Rasayana*, and *Vrishya* have been advocated in the classics for the patients of *Mamsakshaya*. *Madhura Rasa*, *Snigdha*, *Guru*, *Sthira Guna*, *Sheeta Virya* of drugs gives relief to vitiated *Vata Dosha*. The ultimate aim of treating *Mamsakshaya* is to achieve a proportionate body. Probable mode of action of *Bhrimhana Dravyas* can be accessed on the ground of its property. It is found that the ingredient has predominance of *Guru*, *Snigdha*, *Shita*, and *Manda Guna*; *Madhura Rasa* and *Madhura Vipaka* lead to *Vatanulomana* and act as *Bhrimhana*.

Nutritional analysis of KP shows the presence of macronutrients such as energy (352.2 kcal), sugar (57.3 g), carbohydrate (77.6%w/w), protein (4.4%w/w), and fat (2.8%w/w)\[[@ref14]\] for each 100 g sample. Major source of energy is macronutrients which are needed for growth, metabolism, and other body metabolism. The present result indicates the potentiality of KP as unconventional food. *Kharjura* is easily accessible and cheaper source of good nutrition. Vitamins C, Vitamins B~1~ thiamine, B~2~ riboflavin, nicotinic acid (niacin), and Vitamin A are present in *Kharjura*. Fourteen varieties of dates have been shown to be as high dietary fiber of 6.4--11.5%,\[[@ref15]\] which depending on variety and degree of ripeness. *Kharjura* contains 0.5--3.9% pectin, which has valuable health benefits. These are attributed to the rich contents of antioxidant in date fruit such as ferulic acid and coumaric acid. Moreover, it contains procyanidins, flavonoids, sterols, sugar (glucose, sucrose, and fructose) carotenoids, anthocyanins, dietary fibers, thiamine, ascorbic, folic acid, and minerals such as cobalt magnesium, fluorine, manganese, calcium, iron, copper, phosphorus, boron, sulfur, zinc potassium, sodium, and selenium within the date palm itself.\[[@ref16]\] Hence, *Kharjura* acts as a good nutritive fruit and also when it made with ghee, then the potency of drug increases.

Probable mode of action of *Kharjurapaka* {#sec2-11}
-----------------------------------------

KP having a property of *Madhura Rasa* (sweet in taste) and *Madhura Vipaka* has diminished the *Vata Dosha*. *Vatanulomana* property of formulation helps in balance and maintenance of *Agni* and ultimately causes proper digestion of food. *Guru*, *Shita*, *Snigdha*, and *Mrudu Gunas* (soft property) are directly responsible for *Bhrimhana* effect.

KP having *Prithvi* and *Jala Mahabhuta* dominance is somewhat equivalent to property of *Mamsa Dhatu*; further, the available nutritive data of *KP* show it a competitive source of nutrition so it helps for nourishment of *Mamsa Dhatu* in better way. The *Kharjura* has maximum essential macronutrients and micronutrients. The prepared KP with ghee is a very well accepted for its palatability and taste.

Conclusion {#sec1-6}
==========

The present clinical study shows that the selected drug KP helps to improve the sign and symptoms of *Mamsakshaya*. KP showed marginal better in comparison with placebo control group. KP is useful for the treatment of *Mamsakshaya*.
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